Citation

Sakauchi N, Kohara Y, Sato A, Suzaki T, Imai Y, Okabe Y, Imai S, Saikawa R, Nagabukuro H, Kuno H, Fujita H, Kamo I, Yoshida M.: Discovery of 5-Chloro-1-(5-chloro-2-(methylsulfonyl)benzyl)-2-imino-1,2-dihydropyridine-3-carboxamide (TAK-259) as a Novel, Selective, and Orally Active α1D Adrenoceptor Antagonist with Antiurinary Frequency Effects: Reducing Human Ether-a-go-go-Related Gene (hERG) Liabilities. J Med Chem, Volume 59 (7), 2016

Authors

Fujita H, Imai S, Imai Y, Kamo I, Kohara Y, Kuno H, Nagabukuro H, Okabe Y, Saikawa R, Sakauchi N, Sato A, Suzaki T, Yoshida M.

Journal

J Med Chem

Year

2016

DOI

10.1021/acs.jmedchem.5b01528

PubMed

26954848

Machine-readable

REST APIRDF